Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

LONDON MARKET CLOSE: Stocks mixed as weak miners weigh in muted trade

6th Jul 2026 17:07

(Alliance News) - The FTSE 100 gave back early gains on Monday as falls in gold miners and AstraZeneca, plus soft construction figures, dampened early enthusiasm. Read More

LONDON BROKER RATINGS: HSBC raises GSK; RBC cuts Close Brothers

6th Jul 2026 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday : Read More

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

2nd Jul 2026 17:04

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike across the pond. Read More

Hutchmed drug approved in China for advanced gastric cancer

2nd Jul 2026 14:26

(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer with "a very poor prognosis". Read More

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises

2nd Jul 2026 10:21

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

LONDON BROKER RATINGS: Deutsche ups RS to buy; Exane neutral on Segro

1st Jul 2026 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2

29th Jun 2026 08:38

(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate in the EU for previously treated patients with HER2-positive metastatic solid tumours. Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

AstraZeneca's, Daiichi's Datroway recommended for further EU approval

26th Jun 2026 12:32

(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of Datroway for a form of breast cancer. Read More

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle

23rd Jun 2026 16:59

(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted mood. Read More

WINNERS & LOSERS: Telecom Plus cuts dividend, warns on profit

23rd Jun 2026 09:58

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses

19th Jun 2026 09:38

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

AstraZeneca's Ultomiris wins US FDA priority review in kidney disease

15th Jun 2026 08:19

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologics licence application for Ultomiris as a treatment for adults with immunoglobulin A nephropathy. Read More

AstraZeneca says Truqap combination approved in US for prostate cancer

12th Jun 2026 21:37

(Alliance News) - AstraZeneca PLC on Friday said a Truqap combination has been approved by the US Food & Drug Administration as a first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer. Read More

LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off

12th Jun 2026 17:07

(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued to dealing screens as trading in SpaceX kicked off. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

AstraZeneca progresses elecoglipron after positive phase IIb results

9th Jun 2026 08:09

(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

7th Jun 2026 16:01

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris. Read More

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

6th Jun 2026 09:11

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the Financial Times in an interview published on Saturday. Read More

12345678910
FTSE 100 Latest
Value10,659.13
Change-157.01